UnitedHealth Group Inc (NYSE:UNH) Holdings Cut by Signature Estate & Investment Advisors LLC

Signature Estate & Investment Advisors LLC lowered its stake in UnitedHealth Group Inc (NYSE:UNH) by 7.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 89,318 shares of the healthcare conglomerate’s stock after selling 7,240 shares during the quarter. UnitedHealth Group comprises approximately 2.0% of Signature Estate & Investment Advisors LLC’s holdings, making the stock its 15th largest holding. Signature Estate & Investment Advisors LLC’s holdings in UnitedHealth Group were worth $17,493,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. HighPoint Advisor Group LLC grew its holdings in shares of UnitedHealth Group by 20.8% in the 3rd quarter. HighPoint Advisor Group LLC now owns 6,139 shares of the healthcare conglomerate’s stock valued at $1,296,000 after acquiring an additional 1,057 shares in the last quarter. DekaBank Deutsche Girozentrale lifted its stake in UnitedHealth Group by 2.0% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 489,647 shares of the healthcare conglomerate’s stock valued at $95,646,000 after purchasing an additional 9,810 shares during the last quarter. Veritas Investment Management LLP lifted its stake in UnitedHealth Group by 2.7% in the 3rd quarter. Veritas Investment Management LLP now owns 456,526 shares of the healthcare conglomerate’s stock valued at $89,388,000 after purchasing an additional 12,055 shares during the last quarter. Sigma Planning Corp lifted its stake in UnitedHealth Group by 2.6% in the 3rd quarter. Sigma Planning Corp now owns 17,506 shares of the healthcare conglomerate’s stock valued at $3,429,000 after purchasing an additional 438 shares during the last quarter. Finally, Adell Harriman & Carpenter Inc. lifted its stake in UnitedHealth Group by 20.8% in the 3rd quarter. Adell Harriman & Carpenter Inc. now owns 17,711 shares of the healthcare conglomerate’s stock valued at $3,469,000 after purchasing an additional 3,050 shares during the last quarter. 86.11% of the stock is currently owned by institutional investors.

In related news, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the sale, the chief executive officer now owns 195,314 shares in the company, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders sold a total of 33,655 shares of company stock valued at $7,469,083 over the last ninety days. 0.89% of the stock is currently owned by insiders.

UnitedHealth Group Inc (NYSE:UNH) opened at $241.61 on Monday. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58. The firm has a market cap of $235,420.00, a PE ratio of 22.56, a PEG ratio of 1.42 and a beta of 0.66. UnitedHealth Group Inc has a fifty-two week low of $156.49 and a fifty-two week high of $244.35.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same period in the previous year, the firm posted $2.11 earnings per share. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. sell-side analysts forecast that UnitedHealth Group Inc will post 12.52 EPS for the current fiscal year.

Several equities research analysts have issued reports on the stock. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective for the company in a research report on Saturday. Argus lifted their price target on shares of UnitedHealth Group to $270.00 and gave the company a “buy” rating in a research report on Thursday. Deutsche Bank lifted their price target on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Citigroup lifted their price target on shares of UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Finally, Piper Jaffray Companies reissued a “buy” rating and issued a $259.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Two equities research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $243.22.

COPYRIGHT VIOLATION WARNING: This article was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The correct version of this article can be read at https://www.dispatchtribunal.com/2018/01/22/signature-estate-investment-advisors-llc-has-17-49-million-holdings-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply